High throughput quantification of quinidine in human plasma by LC/MS/MS for therapeutic drug monitoring

Farmacia

Volumn 58, Issue 2, 2010, Pages 184-189

  Vlase, Laurian ^a   Mîndruţǎu, Ioana ^a   Muntean, Dana ^a   Iacob, Daniela ^a   Leucuţa, Sorin E ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Liquid chromatography; Mass spectrometry; Quinidine

Indexed keywords

QUINIDINE;

ARTICLE; CHEMICAL STRUCTURE; DRUG MONITORING; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; ION TRAP MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY;

EID: 77951564815     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Drayer E., Lorenzo B., Reidenberg M.M., Liquid chromatography and fluorescence spectroscopy compared with a homogeneous enzyme immunoassay technique for determining quinidine in serum. Clin. Chem., 1981, 27(2), 308-310. (Pubitemid 11117439)
2. Meineke I., Rohde S., Gundert-Remy U., An inexpensive and sensitive method for the determination of quinidine in plasma by high-performance liquid chromatography with ultraviolet detection, Ther. Drug. Monit., 1995, 17(1), 75-78.
3. Nielsen F., Nielsen K.K., Brosen K., Determination of quinidine, dihydroquinidine, (3S) - 3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high performance liquid chromatography. J. Chromatogr. B Biomed. Appl., 1994, 660, 103-110. (Pubitemid 24362384)
4. Zaugg S., Thormann W., Capillary electrophoretic separation, immunochemical recognition and analysis of the diastereomers quinine and quinidine and two quinidine metabolites in body fluids, J. Pharm. Biomed. Anal., 2001, 24, 785-799. (Pubitemid 32209135)
5. U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry - Bioanalytical Method Validation, 2001, http://www.fda.gov/cvm.
6. The European Agency for the Evaluation of Medicinal Products, Note for Guidance on the Investigation of Bioavailability and Bioequivalence, 2001, http://www.eudra.org/emea.html.
7. Iuga C., Bojiţǎ M., Leucuţa S.E, Development of a validated RP-HPLC method for separation and determination of process-related impurities of omeprazole in bulk drugs. Farmacia. 2009, 57(5), 534-541
8. Gruia V., Arama C., Mitrea N., Arsene A. L., Gradinaru D., Dragoi C., The HPLC plasmatic profile of some fat-soluble antioxidant micronutrients (all-trans-retinol, α- tocopherol, coenzime Q10) in diabetic and dyslipidemic patients. Farmacia, 2009, 57(5), 630-638
9. Popa D.S., Vlase L., Leucuţa S.E., Loghin F., Determination of cocaine and benzoylecgonine in human plasma by LC-MS/MS, Farmacia, 2009, 57(3), 301-308
10. Florea M., Aramǎ C.C., Monciu C.M., Determination of terbinafine hydrochloride by ion-pair reversed phase liquid chromatography, Farmacia, 2009, 57(1), 82-88
11. Tero-Vescan A., Imre S., Vari C.E., Oşan A., Dogaru M.T., Csedö C., Determination of some isoflavonoids and flavonoids from Genista Tinctoria L by HPLC-UV, Farmacia, 2009, 57(1), 120-127